These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10073051)

  • 21. [4-Log leukocyte depletion of erythrocyte concentrates--a comparison with 3 other filters].
    Richter E; Matthes G; Tofoté U; Rath E; Takahashi TA; Hosoda M; Sekiguchi S
    Beitr Infusionsther Transfusionsmed; 1994; 32():26-8. PubMed ID: 9480103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of concurrent red blood cell and platelet collection by apheresis in a university haemapheresis unit.
    Moog R
    Transfus Med; 2004 Apr; 14(2):145-50. PubMed ID: 15113378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and storage of white blood cell-reduced split apheresis platelet concentrates for pediatric use.
    van der Meer PF; Vrielink H; Pietersz RN
    Transfusion; 2005 Feb; 45(2):223-7. PubMed ID: 15660831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
    Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
    J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside.
    Cardo LJ; Salata J; Harman R; Mendez J; Weina PJ
    Transfusion; 2006 Jun; 46(6):896-902. PubMed ID: 16734805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods.
    Dijkstra-Tiekstra MJ; van der Schoot CE; Pietersz RN; Reesink HW
    Vox Sang; 2005 May; 88(4):275-7. PubMed ID: 15877650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality assessment of platelet concentrate prepared at a tertiary centre in Nigeria.
    Fasola FA; Okunade MA; Abjah UM
    Afr J Med Med Sci; 2002 Dec; 31(4):337-9. PubMed ID: 15027775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products.
    Santana JM; Dumont LJ
    Transfusion; 2006 Jun; 46(6):966-72. PubMed ID: 16734813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Labile blood products and their preparation].
    Chabanel A; Folléa G
    Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004.
    Fang CT; Chambers LA; Kennedy J; Strupp A; Fucci MC; Janas JA; Tang Y; Hapip CA; Lawrence TB; Dodd RY;
    Transfusion; 2005 Dec; 45(12):1845-52. PubMed ID: 16371037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the improvement of leucodepletion performance of the Haemonetics MCS+ for production of leucodepleted platelet concentrate.
    Seghatchian J; Beard MJ; Krailadsiri P
    Platelets; 2001 Aug; 12(5):298-301. PubMed ID: 11487382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
    Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
    Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood component separation with gravity filtration: production of leukocyte-depleted erythrocyte concentrates].
    Taborski U; Kollig J; Müller-Berghaus G
    Beitr Infusionsther Transfusionsmed; 1994; 32():16-9. PubMed ID: 9480075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.